Stryker Corp (NYSE:SYK)

CAPS Rating: 5 out of 5

A medical technology company in orthopaedics products. Its products include implants, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation.

Results 1 - 20 of 202 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar OKwarrior (26.13) Submitted: 5/10/2014 3:39:42 PM : Outperform Start Price: $80.50 SYK Score: -4.48

Staying with the large caps. Stryker is the premier maker of hospital beds in addition to a lot of high margin orthopedic appliances. FCF has been on the upswing for some years. The PE is kinda high but the growth is steady and dividends are following (though only 1.3% yield).

Recs

1
Member Avatar Dividends500 (66.01) Submitted: 4/3/2014 1:01:33 AM : Outperform Start Price: $79.93 SYK Score: -8.32

Dividends500 tracks the 200 strongest dividends in the S&P 500. To qualify as a strong dividend, the company must meet two simple requirements:

- A payout ratio below 50%
- An increasing dividend from the prior year

Because there are more than 200 dividend paying companies in the S&P 500 that meet these requirements, the qualifying companies with the largest dividend yields were chosen.

Dividends500 intends to test this FactSet article, which highlights these strong dividend paying companies and their outperformance versus the S&P 500 as a whole (Page 12).

http://www.factset.com/websitefiles/PDFs/dividend/dividend_12.16.13

If you have questions or see something you think is inaccurate feel free to let me know.

Recs

0
Member Avatar afewgoodstocks11 (27.91) Submitted: 12/30/2013 11:06:56 AM : Outperform Start Price: $47.15 SYK Score: +13.17

Div. (Yield) $1.06 (1.6%)
Current Yield . . . . . . 2.56%

Recs

0
Member Avatar bvander (< 20) Submitted: 10/26/2013 4:43:01 PM : Outperform Start Price: $73.67 SYK Score: -2.91

Solid company. I want to hold them for the long haul and hope they can pull off another 25 year run.

Recs

0
Member Avatar Sicb (< 20) Submitted: 10/25/2013 3:59:20 PM : Outperform Start Price: $73.76 SYK Score: -2.95

Stryker Corporation (Stryker) is a medical technology company. Stryker offers a diverse array of medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products. The Company operates in three business segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Its products include implants used in joint replacement, trauma, and spinal surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment, as well as other medical device products used in a variety of medical specialties. Internationally, its products are sold in over 100 countries through Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors. In 2012, the Company completed the acquisition of Surpass Medical, Ltd. (Surpass). Effective March 1, 2013, Stryker Corp acquired the share capital of Trauson Holdings Co Ltd.

Recs

0
Member Avatar LESLIEKATZ (< 20) Submitted: 10/8/2013 12:36:56 PM : Outperform Start Price: $67.32 SYK Score: +0.93

mako acquistion will be instrumental in growing Stykers earnings. Their sales force and financing abilities will lead to substantial growth in the mako division

Recs

0
Member Avatar Flygal5 (99.00) Submitted: 9/30/2013 12:14:15 PM : Outperform Start Price: $66.90 SYK Score: +2.91

top performing medical equipment company

Recs

0
Member Avatar dcranage (< 20) Submitted: 8/10/2013 10:02:30 AM : Outperform Start Price: $69.30 SYK Score: -0.92

A 10X'er company, strong leadership, aging population

Recs

0
Member Avatar 1smallfry (57.27) Submitted: 7/26/2013 11:37:26 PM : Outperform Start Price: $69.58 SYK Score: -1.23

Yes

Recs

0
Member Avatar 2trpop (93.24) Submitted: 7/25/2013 2:45:03 PM : Outperform Start Price: $69.53 SYK Score: -1.12

fstg experiment

Recs

0
Member Avatar Teacherman333 (44.64) Submitted: 6/2/2013 1:57:01 PM : Outperform Start Price: $66.69 SYK Score: -0.14

For reference point and to allow for comments by others. As of the end of March, 2013.

ROE 15.20%%
Trailing PE 20.30
PB 3.01
Div yield 1.60%

Recs

0
Member Avatar CarlosDK (21.10) Submitted: 1/16/2013 4:21:30 AM : Underperform Start Price: $58.07 SYK Score: -4.22

to hs on weekly

Recs

1
Member Avatar mikeinmadrid (91.63) Submitted: 9/14/2012 8:18:50 AM : Outperform Start Price: $53.45 SYK Score: +16.25

About half of Stryker's revenue comes from reconstructive orthopedic implants, where the firm is a top-tier provider of knees and hips. Demographic trends of obesity and increased life span.

Stock price has gone net nowhere since 2004, as eps increased p/e has decreased form 40x to 15x (i.e. growth was priced in).

M* FV est. $63. Not that excitingly cheap at $55. Look for price closer to recent lows of $45.

Recs

0
Member Avatar beefangusbeef (67.63) Submitted: 9/4/2012 4:19:03 PM : Outperform Start Price: $52.08 SYK Score: +14.70

Aging population needs new joints.

Recs

0
Member Avatar chaddibanyan (< 20) Submitted: 7/26/2012 12:20:24 PM : Outperform Start Price: $49.72 SYK Score: +16.37

will cross 53

Recs

0
Member Avatar line70day (< 20) Submitted: 7/19/2012 9:53:39 AM : Outperform Start Price: $50.66 SYK Score: +15.52

second Q earnings rose 4.8% higher domestic sales working to get more products approved last Q profit 85 cents a share compared to yr earlier Net sale increased 2.9% sales up 2.7%

Recs

0
Member Avatar valuemoneygreen (84.36) Submitted: 7/11/2012 4:29:26 AM : Outperform Start Price: $50.56 SYK Score: +11.06

Stryker is like my #1 pick for the medical products industry. This company has made money forever and will no doubt in my mind continue to do so. A PE of 13.1 on this years estimates. 10% growth over the next 5 years. Return on capital of 16% on average over the last five years. Don't stop there look at the last 20. These guys remind me of ABT for some reason. Long history and a good track record in the healthcare industry.

Recs

1
Member Avatar jrawk28 (< 20) Submitted: 1/15/2012 12:33:20 PM : Outperform Start Price: $50.26 SYK Score: +8.51

Aging demographics, no patent cliff as with pharmaceuticals.

Recs

0
Member Avatar torpeydo (< 20) Submitted: 11/15/2011 5:52:18 PM : Outperform Start Price: $46.82 SYK Score: +13.85

baby boomers getting older

Recs

0
Member Avatar theojob (< 20) Submitted: 10/17/2011 10:42:25 PM : Outperform Start Price: $46.32 SYK Score: +9.57

Quality care!

Featured Broker Partners


Advertisement